Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Tight junction (mmu04530)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
2900073G
15Rik
KLA  ATP  ATP+KLA
 NM_026064 RIKEN cDNA 2900073G15 gene (2900073G15Rik), mRNA [NM_026064] KLA 1.50 1.46 1.64 1.51 1.69 1.72 1.15
ATP 1.05 1.10 1.24 1.39 1.23 1.13 1.03
KLA/ATP 1.50 1.60 1.64 1.71 1.36 1.21 1.11
4930468A
15Rik
KLA  ATP  ATP+KLA
 AK015525 adult male testis cDNA, RIKEN full-length enriched library, clone:4930468A15 product:hypothetical protein, full insert sequence [AK015525] KLA .97 1.00 1.03 .98 1.02 1.01 1.02
ATP 1.03 .97 1.05 1.02 .99 .98 .98
KLA/ATP 1.01 1.00 .97 1.01 .95 .98 .96
Actb
KLA  ATP  ATP+KLA
 BC016624 cDNA clone IMAGE:4501052 [BC016624] KLA 1.20 1.20 1.19 1.73 1.83 2.52 1.70
ATP 1.04 1.01 1.03 .92 1.07 .66 .91
KLA/ATP 1.34 1.40 1.69 1.28 1.27 1.19 1.06
Actb
KLA  ATP  ATP+KLA
 NM_007393 actin, beta, cytoplasmic (Actb), mRNA [NM_007393] KLA 1.58 1.64 1.59 2.02 2.03 3.04 1.75
ATP 1.00 .95 1.26 1.18 1.33 .86 .91
KLA/ATP 1.52 1.75 2.42 1.92 2.17 1.54 1.28
Actg1
KLA  ATP  ATP+KLA
 NM_009609 actin, gamma, cytoplasmic 1 (Actg1), mRNA [NM_009609] KLA 1.02 1.03 1.34 1.07 1.49 1.58 .71
ATP 1.07 1.24 .76 .76 .63 .46 .78
KLA/ATP 1.20 1.30 .75 .82 .60 .53 .55
Actn1
KLA  ATP  ATP+KLA
 NM_134156 actinin, alpha 1 (Actn1), mRNA [NM_134156] KLA 1.33 1.42 1.46 1.16 1.18 .69 .54
ATP 1.06 1.13 .67 1.15 .95 .99 1.46
KLA/ATP 1.66 1.64 .81 1.55 .82 .78 .76
Actn2
KLA  ATP  ATP+KLA
 NM_033268 actinin alpha 2 (Actn2), mRNA [NM_033268] KLA 1.03 .94 1.02 1.05 1.02 1.06 1.11
ATP 1.04 .98 1.07 .99 1.10 1.03 1.02
KLA/ATP 1.06 1.03 .99 1.08 1.01 1.05 .98
Actn3
KLA  ATP  ATP+KLA
 NM_013456 actinin alpha 3 (Actn3), mRNA [NM_013456] KLA .97 .98 .98 .94 1.03 .96 1.07
ATP .95 .95 1.02 .98 .94 .95 1.01
KLA/ATP 1.05 1.03 .94 1.03 1.03 1.00 .95
Actn4
KLA  ATP  ATP+KLA
 NM_021895 actinin alpha 4 (Actn4), mRNA [NM_021895] KLA .78 .77 .75 .74 .58 .51 .65
ATP 1.03 1.03 1.21 1.14 1.50 1.30 1.09
KLA/ATP .78 .85 .96 .84 1.09 1.12 .97
AK049504
KLA  ATP  ATP+KLA
 AK049504 7 days embryo whole body cDNA, RIKEN full-length enriched library, clone:C430017P18 product:hypothetical protein, full insert sequence. [AK049504] KLA 1.03 .99 .99 1.03 1.03 .98 .94
ATP .96 1.04 1.03 1.02 1.01 1.02 .98
KLA/ATP 1.03 .99 1.06 .98 .97 .94 1.06
AK078768
KLA  ATP  ATP+KLA
 AK078768 15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030463G20 product:unclassifiable, full insert sequence. [AK078768] KLA 1.00 1.04 1.01 1.00 1.01 .99 .92
ATP .94 1.03 1.07 .96 .97 .95 .99
KLA/ATP .95 .99 1.02 1.04 .99 .99 1.01
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
Amotl1
KLA  ATP  ATP+KLA
 NM_001081395 angiomotin-like 1 (Amotl1), mRNA [NM_001081395] KLA .97 .96 .89 .87 .94 .94 .95
ATP 1.03 1.05 1.00 .98 .97 1.06 1.13
KLA/ATP .95 .92 .90 .95 .93 .94 .99
Ash1l
KLA  ATP  ATP+KLA
 NM_138679 ash1 (absent, small, or homeotic)-like (Drosophila) (Ash1l), mRNA [NM_138679] KLA 1.23 1.04 1.03 1.04 1.29 1.17 1.27
ATP 1.18 1.23 1.32 1.55 1.83 1.60 1.35
KLA/ATP 1.25 1.19 1.22 1.25 1.54 1.57 1.72
B230120H
23Rik
KLA  ATP  ATP+KLA
 NM_023057 RIKEN cDNA B230120H23 gene (B230120H23Rik), transcript variant 1, mRNA [NM_023057] KLA 1.35 1.36 1.17 .91 .69 .43 .56
ATP 1.01 1.12 .87 1.32 1.71 1.48 .63
KLA/ATP 1.37 1.46 .95 1.14 1.07 1.22 .78
B230120H
23Rik
KLA  ATP  ATP+KLA
 NM_178084 RIKEN cDNA B230120H23 gene (B230120H23Rik), transcript variant 2, mRNA [NM_178084] KLA 1.08 1.07 1.06 1.00 .87 .62 .68
ATP 1.11 1.24 1.41 1.31 1.49 1.04 .79
KLA/ATP 1.13 1.24 1.17 1.07 1.04 .89 .85
Cask
KLA  ATP  ATP+KLA
 NM_009806 calcium/calmodulin-dependent serine protein kinase (MAGUK family) (Cask), mRNA [NM_009806] KLA 1.92 2.00 2.43 2.97 2.71 1.46 1.01
ATP .96 .99 .90 .88 .75 1.08 .74
KLA/ATP 1.72 1.79 1.84 1.57 1.23 1.06 .75
Cdc42
KLA  ATP  ATP+KLA
 NM_009861 cell division cycle 42 homolog (S. cerevisiae) (Cdc42), mRNA [NM_009861] KLA 1.04 1.01 1.02 1.04 1.12 1.21 1.12
ATP 1.07 1.10 1.04 1.06 1.02 .95 1.14
KLA/ATP .94 1.04 1.01 .97 .95 1.02 1.25
Cdk4
KLA  ATP  ATP+KLA
 NM_009870 cyclin-dependent kinase 4 (Cdk4), mRNA [NM_009870] KLA .66 .72 .65 .55 .46 .50 .71
ATP 1.03 1.02 .53 .65 .66 .63 .75
KLA/ATP .78 .61 .31 .42 .44 .62 .43
CF586908
KLA  ATP  ATP+KLA
 CF586908 gb|AGENCOURT_8784932_updated NIH_MGC_140 Mus musculus cDNA clone IMAGE:6436450 5, mRNA sequence [CF586908] KLA 1.01 1.01 1.01 .98 1.04 1.04 1.05
ATP 1.03 .94 1.02 1.07 1.07 1.01 1.07
KLA/ATP .99 1.00 1.04 1.11 1.14 1.04 1.00
Cgn
KLA  ATP  ATP+KLA
 AK018143 adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330408J11 product:similar to CINGULIN [Homo sapiens], full insert sequence. [AK018143] KLA 1.01 1.00 1.04 1.01 1.11 1.08 1.02
ATP .97 .96 1.02 1.02 .95 .96 1.04
KLA/ATP .93 1.07 .95 .97 1.00 .96 .99
Cgn
KLA  ATP  ATP+KLA
 XM_001001375 gb|PREDICTED: Mus musculus cingulin (Cgn), mRNA [XM_001001375] KLA .99 .99 1.05 .94 1.01 .97 .95
ATP .96 1.05 1.02 .94 .97 .97 .95
KLA/ATP .96 1.01 .99 1.01 .97 .93 .99
Cldn1
KLA  ATP  ATP+KLA
 NM_016674 claudin 1 (Cldn1), mRNA [NM_016674] KLA .97 1.02 1.02 1.05 1.05 .99 1.07
ATP 1.02 .94 1.03 1.08 1.05 .98 1.02
KLA/ATP 1.03 1.02 1.00 1.00 1.17 1.01 1.03
Cldn10
KLA  ATP  ATP+KLA
 NM_021386 claudin 10 (Cldn10), transcript variant 2, mRNA [NM_021386] KLA 1.06 1.05 1.04 1.12 1.08 1.05 1.04
ATP 1.07 .97 .98 1.06 1.00 1.01 .97
KLA/ATP 1.01 1.06 .86 .98 1.03 1.04 1.09
Cldn11
KLA  ATP  ATP+KLA
 NM_008770 claudin 11 (Cldn11), mRNA [NM_008770] KLA 1.05 1.10 1.04 .99 .97 .99 .97
ATP 1.03 1.01 1.08 3.05 1.24 1.11 1.07
KLA/ATP 1.02 .96 1.42 2.53 1.09 1.02 1.03
Cldn13
KLA  ATP  ATP+KLA
 NM_020504 claudin 13 (Cldn13), mRNA [NM_020504] KLA 1.02 1.00 1.02 .97 1.01 .98 .99
ATP .92 .96 1.05 .96 1.02 1.04 1.04
KLA/ATP .93 .94 1.10 1.06 1.00 .93 1.03
Cldn14
KLA  ATP  ATP+KLA
 NM_019500 claudin 14 (Cldn14), mRNA [NM_019500] KLA 1.03 1.12 1.14 1.08 1.09 1.16 1.08
ATP 1.03 .99 1.12 1.04 1.07 1.10 1.06
KLA/ATP 1.07 1.14 1.21 1.12 1.07 1.10 1.08
Cldn15
KLA  ATP  ATP+KLA
 NM_021719 claudin 15 (Cldn15), mRNA [NM_021719] KLA 1.01 1.07 1.04 1.09 1.06 1.11 .98
ATP 1.17 1.26 1.27 1.08 1.24 1.11 1.05
KLA/ATP 1.25 1.31 1.19 1.22 1.70 1.26 1.03
Cldn16
KLA  ATP  ATP+KLA
 NM_053241 claudin 16 (Cldn16), mRNA [NM_053241] KLA 1.08 .98 1.02 1.00 1.06 1.05 1.00
ATP 1.01 1.05 1.01 1.12 1.05 .98 .99
KLA/ATP .98 .95 1.04 1.05 1.02 1.15 1.01
Cldn17
KLA  ATP  ATP+KLA
 NM_181490 claudin 17 (Cldn17), mRNA [NM_181490] KLA .99 1.05 1.01 1.00 .97 .99 1.01
ATP .95 .98 1.06 1.05 .97 1.00 1.00
KLA/ATP 1.04 1.00 .95 1.05 .96 1.02 1.11
Cldn18
KLA  ATP  ATP+KLA
 NM_019815 claudin 18 (Cldn18), mRNA [NM_019815] KLA .99 1.06 .99 .99 1.03 1.13 1.11
ATP .96 1.00 1.10 .98 .95 .98 1.07
KLA/ATP 1.07 .95 1.05 1.07 1.11 1.06 1.02
Cldn19
KLA  ATP  ATP+KLA
 NM_001038590 claudin 19 (Cldn19), transcript variant 1, mRNA [NM_001038590] KLA 1.06 .92 1.01 1.01 1.03 .96 1.00
ATP 1.00 .97 1.05 .93 .95 .91 1.01
KLA/ATP .93 .99 .96 .93 .91 .92 .93
Cldn19
KLA  ATP  ATP+KLA
 NM_153105 claudin 19 (Cldn19), transcript variant 2, mRNA [NM_153105] KLA .97 1.01 1.02 1.05 1.06 .96 1.09
ATP 1.04 .98 1.08 1.02 .98 1.00 .96
KLA/ATP 1.02 1.03 1.03 1.02 1.00 1.02 1.03
Cldn2
KLA  ATP  ATP+KLA
 NM_016675 claudin 2 (Cldn2), mRNA [NM_016675] KLA .98 .93 1.02 1.04 1.00 1.03 1.01
ATP 1.01 1.01 1.00 1.06 1.01 .99 1.08
KLA/ATP 1.07 1.01 .72 1.04 1.04 1.04 1.00
Cldn22
KLA  ATP  ATP+KLA
 NM_029383 claudin 22 (Cldn22), mRNA [NM_029383] KLA .99 .99 .99 .99 .99 .98 .96
ATP 1.01 .95 .99 .98 1.06 .92 .98
KLA/ATP 1.02 1.07 .96 1.00 1.02 1.04 .99
Cldn23
KLA  ATP  ATP+KLA
 NM_027998 claudin 23 (Cldn23), mRNA [NM_027998] KLA 1.33 1.38 1.29 1.23 1.13 1.13 1.20
ATP .99 1.04 1.11 1.41 1.44 1.23 1.14
KLA/ATP 1.42 1.34 1.29 1.33 1.30 1.23 1.73
Cldn3
KLA  ATP  ATP+KLA
 NM_009902 claudin 3 (Cldn3), mRNA [NM_009902] KLA 1.04 1.02 1.06 1.09 1.08 1.13 1.09
ATP 1.02 1.02 1.06 1.03 1.01 1.00 1.01
KLA/ATP 1.07 1.05 1.19 1.10 1.07 1.13 1.15
Cldn4
KLA  ATP  ATP+KLA
 NM_009903 claudin 4 (Cldn4), mRNA [NM_009903] KLA 1.05 .99 .94 1.02 1.05 1.05 .98
ATP 1.01 1.04 1.01 .95 .96 1.09 1.09
KLA/ATP .98 1.11 1.08 1.05 .86 .95 1.07
Cldn5
KLA  ATP  ATP+KLA
 NM_013805 claudin 5 (Cldn5), mRNA [NM_013805] KLA 1.08 1.08 1.23 1.13 1.16 1.18 1.18
ATP 1.01 1.02 1.03 1.03 1.05 1.00 1.06
KLA/ATP 1.14 1.18 1.13 1.09 1.05 1.15 1.16
Cldn6
KLA  ATP  ATP+KLA
 NM_018777 claudin 6 (Cldn6), mRNA [NM_018777] KLA 1.06 1.04 .98 1.01 1.03 .99 .91
ATP .98 1.01 .94 .99 .95 1.14 1.07
KLA/ATP 1.02 .96 1.08 1.04 1.01 .95 1.05
Cldn7
KLA  ATP  ATP+KLA
 NM_016887 claudin 7 (Cldn7), mRNA [NM_016887] KLA 1.21 1.23 1.33 1.38 1.44 1.26 1.01
ATP 1.01 1.01 1.07 1.01 1.04 1.04 1.03
KLA/ATP 1.22 1.28 1.24 2.23 1.42 1.17 1.07
Cldn8
KLA  ATP  ATP+KLA
 NM_018778 claudin 8 (Cldn8), mRNA [NM_018778] KLA .98 .86 1.00 .98 1.02 1.06 .97
ATP .93 .99 1.01 1.00 1.05 1.01 1.03
KLA/ATP .98 1.08 .96 1.00 1.02 .98 1.00
Cldn9
KLA  ATP  ATP+KLA
 NM_020293 claudin 9 (Cldn9), mRNA [NM_020293] KLA 1.29 1.24 1.37 1.34 1.32 1.37 1.55
ATP .92 .90 1.30 1.47 1.43 1.32 1.12
KLA/ATP 1.16 1.26 2.03 1.63 1.89 1.39 1.30
Crb3
KLA  ATP  ATP+KLA
 NM_177638 crumbs homolog 3 (Drosophila) (Crb3), mRNA [NM_177638] KLA 1.00 .97 .98 1.00 1.01 .98 .94
ATP .97 .93 .94 1.00 .97 .93 .98
KLA/ATP .93 .97 1.02 .97 .93 .97 1.00
Csda
KLA  ATP  ATP+KLA
 NM_011733 cold shock domain protein A (Csda), mRNA [NM_011733] KLA 1.34 1.53 1.48 1.32 1.34 1.02 1.07
ATP 1.02 1.24 1.10 1.69 1.33 .90 .63
KLA/ATP 1.39 1.62 1.20 1.75 1.04 .88 .52
Csnk2a1
KLA  ATP  ATP+KLA
 NM_007788 casein kinase 2, alpha 1 polypeptide (Csnk2a1), mRNA [NM_007788] KLA 1.36 1.39 1.19 1.34 1.32 1.74 1.86
ATP .92 .88 1.13 .86 1.12 2.50 1.99
KLA/ATP 1.19 1.24 1.35 1.03 1.16 2.09 2.88
Csnk2a2
KLA  ATP  ATP+KLA
 NM_009974 casein kinase 2, alpha prime polypeptide (Csnk2a2), mRNA [NM_009974] KLA 1.46 1.53 1.70 1.47 1.32 1.32 1.17
ATP 1.00 1.11 1.17 1.33 1.71 2.03 1.06
KLA/ATP 1.58 1.67 1.69 2.00 2.20 2.44 1.68
Csnk2b
KLA  ATP  ATP+KLA
 NM_009975 casein kinase 2, beta polypeptide (Csnk2b), mRNA [NM_009975] KLA 1.19 1.10 1.12 1.13 1.20 1.28 1.25
ATP 1.12 1.03 1.04 1.07 1.20 1.27 1.09
KLA/ATP 1.15 1.20 1.25 1.13 1.44 1.34 1.35
Ctnna1
KLA  ATP  ATP+KLA
 AK008121 adult male small intestine cDNA, RIKEN full-length enriched library, clone:2010005H04 product:unclassifiable, full insert sequence. [AK008121] KLA .82 .76 .72 .81 .94 .74 .80
ATP 1.08 1.01 .51 .57 2.45 1.25 .95
KLA/ATP .91 .82 .76 .58 1.58 1.01 .92
Ctnna1
KLA  ATP  ATP+KLA
 NM_009818 catenin (cadherin associated protein), alpha 1 (Ctnna1), mRNA [NM_009818] KLA .97 .91 1.06 .84 .75 .52 .56
ATP 1.09 1.14 1.00 .86 .80 .98 .83
KLA/ATP 1.02 1.07 .90 .80 .66 .59 .57
Ctnna2
KLA  ATP  ATP+KLA
 AK035033 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430076K22 product:hypothetical Vinculin and alpha-catenin containing protein, full insert sequence [AK035033] KLA 1.05 1.11 1.12 1.05 1.02 1.04 1.19
ATP .99 .97 1.00 1.05 1.02 1.05 1.03
KLA/ATP 1.11 1.06 1.01 1.12 1.06 1.02 1.03
Ctnna3
KLA  ATP  ATP+KLA
 AK029664 adult male testis cDNA, RIKEN full-length enriched library, clone:4930438F12 product:unclassifiable, full insert sequence. [AK029664] KLA 1.03 1.06 .99 1.05 .95 1.01 1.04
ATP 1.03 1.05 1.02 1.04 .99 1.03 1.05
KLA/ATP 1.01 1.00 .99 1.01 1.00 .98 1.05
Ctnna3
KLA  ATP  ATP+KLA
 NM_177612 catenin (cadherin associated protein), alpha 3 (Ctnna3), mRNA [NM_177612] KLA 1.01 1.06 .98 1.04 1.03 1.04 1.07
ATP .96 1.02 .94 1.11 1.02 1.09 .91
KLA/ATP 1.01 .94 .94 1.10 1.10 1.04 1.04
Ctnnb1
KLA  ATP  ATP+KLA
 AK020013 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830416C23 product:catenin beta, full insert sequence. [AK020013] KLA 1.06 1.15 1.00 1.06 1.27 1.14 1.03
ATP .85 .57 1.74 3.36 4.13 2.19 1.55
KLA/ATP 1.12 .87 2.47 3.61 3.79 2.21 2.06
Ctnnb1
KLA  ATP  ATP+KLA
 NM_007614 catenin (cadherin associated protein), beta 1 (Ctnnb1), mRNA [NM_007614] KLA 1.02 1.07 1.13 1.03 1.04 .93 .96
ATP 1.12 1.14 .75 .77 .73 .72 1.52
KLA/ATP 1.18 1.17 .77 .85 .60 .59 1.35
Cttn
KLA  ATP  ATP+KLA
 NM_007803 cortactin (Cttn), mRNA [NM_007803] KLA 1.12 1.14 1.28 1.32 1.64 2.25 2.00
ATP 1.04 1.02 .98 1.03 1.02 1.21 1.50
KLA/ATP 1.14 1.20 1.09 1.19 1.15 1.54 2.16
Epb4.1
KLA  ATP  ATP+KLA
 AK034678 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430023J17 product:unclassifiable, full insert sequence [AK034678] KLA .30 .28 .20 .16 .19 .36 .62
ATP .99 1.08 .87 .97 .57 .36 .68
KLA/ATP .30 .27 .18 .25 .36 .64 .92
Epb4.1
KLA  ATP  ATP+KLA
 NM_183428 erythrocyte protein band 4.1 (Epb4.1), mRNA [NM_183428] KLA .53 .56 .46 .44 .44 .61 .79
ATP 1.09 1.20 .92 1.03 .67 .56 1.03
KLA/ATP .60 .56 .50 .53 .53 .81 1.38
Epb4.1l1
KLA  ATP  ATP+KLA
 NM_001003815 erythrocyte protein band 4.1-like 1 (Epb4.1l1), transcript variant 2, mRNA [NM_001003815] KLA .73 .70 .59 .69 .82 1.21 1.03
ATP .96 .81 .57 .59 .59 .70 1.97
KLA/ATP .73 .64 .56 .53 .52 .65 1.85
Epb4.1l2
KLA  ATP  ATP+KLA
 NM_013511 erythrocyte protein band 4.1-like 2 (Epb4.1l2), mRNA [NM_013511] KLA 1.09 1.14 1.11 .84 .71 .98 1.04
ATP 1.05 1.18 1.06 1.13 1.31 1.10 1.32
KLA/ATP 1.19 1.16 .97 1.03 1.07 1.15 1.28
Epb4.1l3
KLA  ATP  ATP+KLA
 AK086340 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930022I19 product:unclassifiable, full insert sequence. [AK086340] KLA 1.02 1.01 1.14 .96 1.03 1.02 .96
ATP .96 1.03 1.03 .94 .97 1.01 1.04
KLA/ATP .98 1.07 .94 .98 .95 .93 1.06
Epb4.1l3
KLA  ATP  ATP+KLA
 NM_013813 erythrocyte protein band 4.1-like 3 (Epb4.1l3), mRNA [NM_013813] KLA 1.01 1.00 1.04 1.09 1.14 1.12 1.22
ATP 1.02 1.04 1.04 1.09 1.06 .98 1.04
KLA/ATP 1.06 .99 .93 1.19 1.07 1.14 1.20
Exoc3
KLA  ATP  ATP+KLA
 NM_177333 exocyst complex component 3 (Exoc3), mRNA [NM_177333] KLA .84 .85 .91 .94 .98 .98 .88
ATP .94 .94 1.12 1.00 .63 .72 1.32
KLA/ATP .80 .83 .93 .89 .76 .75 1.10
Exoc4
KLA  ATP  ATP+KLA
 AK014499 14 days embryo liver cDNA, RIKEN full-length enriched library, clone:4432416A01 product:SEC8 (S. cerevisiae), full insert sequence. [AK014499] KLA 1.12 1.15 1.08 1.02 .91 .78 .91
ATP 1.07 1.25 1.22 1.30 1.02 .80 .69
KLA/ATP 1.12 1.31 .96 1.02 .86 .75 .74
Exoc4
KLA  ATP  ATP+KLA
 AK038125 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130080K06 product:SEC8 (S. cerevisiae), full insert sequence [AK038125] KLA 1.00 .98 .87 .90 .97 .88 .76
ATP 1.03 1.12 .97 .74 .77 .83 .76
KLA/ATP .97 .85 .94 .74 .86 .74 .73
Exoc4
KLA  ATP  ATP+KLA
 NM_009148 exocyst complex component 4 (Exoc4), mRNA [NM_009148] KLA 1.11 1.13 1.05 1.02 .96 .83 .56
ATP 1.06 1.08 .99 1.21 .93 .39 .51
KLA/ATP 1.17 1.15 1.14 1.21 .85 .45 .50
F11r
KLA  ATP  ATP+KLA
 NM_172647 F11 receptor (F11r), mRNA [NM_172647] KLA 7.81 8.47 6.77 8.24 6.97 3.97 1.27
ATP .91 .90 1.38 1.45 3.39 8.01 2.55
KLA/ATP 6.57 8.31 8.96 8.00 8.69 7.39 14.52
Gnai1
KLA  ATP  ATP+KLA
 NM_010305 guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] KLA .95 1.01 1.01 1.00 1.09 1.10 1.08
ATP 1.06 1.06 .99 1.15 1.02 .94 .99
KLA/ATP 1.02 1.04 .99 1.16 1.01 1.02 1.13
Gnai2
KLA  ATP  ATP+KLA
 NM_008138 guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] KLA .74 .79 .82 .74 .91 .97 1.10
ATP 1.07 1.16 .78 1.12 .78 .48 .82
KLA/ATP .91 .81 .53 .80 .60 .68 .87
Gnai3
KLA  ATP  ATP+KLA
 NM_010306 guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] KLA 1.23 1.24 1.14 1.06 .99 1.15 1.09
ATP .96 .93 .86 .64 1.34 2.02 1.35
KLA/ATP 1.20 1.24 .97 .76 1.21 1.62 1.17
Hcls1
KLA  ATP  ATP+KLA
 NM_008225 hematopoietic cell specific Lyn substrate 1 (Hcls1), mRNA [NM_008225] KLA 1.40 1.40 1.33 1.57 2.01 2.26 2.51
ATP 1.12 1.08 .92 .87 .83 1.27 1.81
KLA/ATP 1.31 1.48 1.39 1.35 1.05 1.17 3.13
Hras1
KLA  ATP  ATP+KLA
 NM_008284 Harvey rat sarcoma virus oncogene 1 (Hras1), mRNA [NM_008284] KLA .79 .82 .77 .82 .94 1.03 1.07
ATP 1.01 .95 .69 .83 .79 1.12 1.15
KLA/ATP .84 .77 .61 .65 .82 1.00 1.05
Igsf5
KLA  ATP  ATP+KLA
 NM_028078 immunoglobulin superfamily, member 5 (Igsf5), mRNA [NM_028078] KLA .95 1.02 1.03 .98 1.03 1.04 1.10
ATP .96 .99 1.08 1.03 .97 .99 1.02
KLA/ATP 1.03 1.03 1.01 1.01 1.04 1.02 .96
Inadl
KLA  ATP  ATP+KLA
 NM_001005784 InaD-like (Drosophila) (Inadl), transcript variant 2, mRNA [NM_001005784] KLA .98 .95 1.00 .96 1.02 .99 1.00
ATP 1.00 .99 .94 .94 1.05 1.17 1.12
KLA/ATP 1.00 .95 .97 1.07 1.00 1.01 1.09
Inadl
KLA  ATP  ATP+KLA
 NM_001005787 InaD-like (Drosophila) (Inadl), transcript variant 4, mRNA [NM_001005787] KLA .98 .93 1.01 .88 .96 .89 .94
ATP 1.07 .97 .99 .96 1.01 1.58 .96
KLA/ATP 1.05 1.04 1.09 1.02 .93 1.72 2.21
Jam2
KLA  ATP  ATP+KLA
 NM_023844 junction adhesion molecule 2 (Jam2), mRNA [NM_023844] KLA 1.84 2.17 1.88 1.76 1.69 1.51 1.46
ATP .97 .93 1.16 1.13 1.15 1.55 1.21
KLA/ATP 1.77 2.07 1.89 1.54 1.41 1.56 1.52
Jam3
KLA  ATP  ATP+KLA
 AK017692 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730470H08 product:junction cell adhesion molecule 3, full insert sequence. [AK017692] KLA .94 1.00 1.01 1.00 1.02 1.00 .93
ATP .97 .99 1.03 .97 .98 .96 .94
KLA/ATP .94 1.04 .94 .91 .93 .87 1.03
Jam3
KLA  ATP  ATP+KLA
 NM_023277 junction adhesion molecule 3 (Jam3), mRNA [NM_023277] KLA .97 1.02 1.06 1.06 1.01 .98 .74
ATP 1.07 1.00 .98 .96 .89 .88 .67
KLA/ATP 1.13 1.07 1.07 .97 .94 .91 .68
Kras
KLA  ATP  ATP+KLA
 NM_021284 v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (Kras), mRNA [NM_021284] KLA .53 .49 .40 .42 .49 .95 1.05
ATP .98 1.01 1.16 1.17 1.39 1.29 1.74
KLA/ATP .50 .47 .50 .56 1.00 1.24 1.58
Llgl1
KLA  ATP  ATP+KLA
 NM_008502 lethal giant larvae homolog 1 (Drosophila) (Llgl1), mRNA [NM_008502] KLA 1.38 1.33 1.49 1.35 1.13 1.21 1.09
ATP .97 1.01 .95 .85 .77 1.31 1.32
KLA/ATP 1.31 1.43 1.28 1.21 1.04 1.38 1.57
Llgl2
KLA  ATP  ATP+KLA
 NM_145438 lethal giant larvae homolog 2 (Drosophila) (Llgl2), mRNA [NM_145438] KLA .79 .70 .69 .79 .97 .98 1.19
ATP 1.06 1.13 .92 .90 1.16 1.79 1.33
KLA/ATP .84 .71 .73 .69 .81 1.58 1.39
LOC10004
6483
KLA  ATP  ATP+KLA
 XM_001476285 ref|PREDICTED: Mus musculus similar to casein kinase II, alpha prime subunit (LOC100046483), mRNA [XM_001476285] KLA .97 .94 .94 .88 .84 .76 .88
ATP 1.06 1.04 .89 .82 .87 .70 .56
KLA/ATP 1.03 1.00 .88 .75 .73 .66 .43
Magi1
KLA  ATP  ATP+KLA
 NM_001083321 membrane associated guanylate kinase, WW and PDZ domain containing 1 (Magi1), transcript variant 4, mRNA [NM_001083321] KLA 1.03 .99 1.02 .98 1.03 .96 .97
ATP .97 1.01 .96 .89 1.03 .86 .94
KLA/ATP 1.01 1.02 1.06 .97 .95 .97 .95
Magi1
KLA  ATP  ATP+KLA
 NM_010367 membrane associated guanylate kinase, WW and PDZ domain containing 1 (Magi1), transcript variant 1, mRNA [NM_010367] KLA 1.05 .91 .92 .91 .86 .77 .67
ATP .99 .90 1.12 .93 .96 .86 .81
KLA/ATP .85 .85 .94 .84 .83 .78 .70
Magi2
KLA  ATP  ATP+KLA
 NM_015823 membrane associated guanylate kinase, WW and PDZ domain containing 2 (Magi2), mRNA [NM_015823] KLA .70 .66 .52 .64 .62 .68 .87
ATP .61 .56 .48 .54 .53 .81 .72
KLA/ATP .44 .46 .40 .49 .47 .57 .54
Magi3
KLA  ATP  ATP+KLA
 AK173225 premature mRNA for mKIAA1634 protein [AK173225] KLA 1.22 1.16 1.12 1.00 .75 .75 .80
ATP .94 .79 .89 .98 1.50 1.27 .90
KLA/ATP 1.24 1.01 .90 .88 1.15 1.21 1.17
Magi3
KLA  ATP  ATP+KLA
 NM_133853 membrane associated guanylate kinase, WW and PDZ domain containing 3 (Magi3), mRNA [NM_133853] KLA 1.01 .99 1.03 .98 .91 .92 .96
ATP 1.07 .91 .83 .87 1.19 1.04 .94
KLA/ATP 1.04 1.06 .90 .90 .90 1.00 1.03
Mllt4
KLA  ATP  ATP+KLA
 NM_010806 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (Mllt4), mRNA [NM_010806] KLA .70 .66 .57 .68 .70 .66 .82
ATP 1.03 1.01 1.05 .96 .76 .91 1.15
KLA/ATP .65 .68 .66 .54 .82 1.14 1.10
Mm.10799
6
KLA  ATP  ATP+KLA
 94407580 Unknown KLA .97 .95 .93 1.00 .95 1.00 1.00
ATP .95 1.03 .96 .92 1.03 .93 1.05
KLA/ATP .99 .91 .97 .92 .90 .90 .92
Mm.13075
2
KLA  ATP  ATP+KLA
 76096373 Unknown KLA 1.29 1.10 1.11 1.17 1.19 1.30 1.11
ATP 1.13 .92 1.53 1.42 1.93 2.06 1.21
KLA/ATP 1.22 1.23 1.76 1.36 2.11 1.90 1.77
Mm.15909
3
KLA  ATP  ATP+KLA
 149272242 Unknown KLA 1.01 .97 1.01 1.01 1.05 1.02 .99
ATP 1.04 1.01 .95 1.02 .99 .94 .96
KLA/ATP .96 1.01 1.04 .94 .94 1.05 .98
Mm.23692
KLA  ATP  ATP+KLA
 164565453 Unknown KLA .83 .77 .72 .65 .61 .75 .80
ATP .77 .94 1.03 .63 .61 .74 .59
KLA/ATP .58 .78 .77 .52 .51 .56 .30
Mm.25070
5
KLA  ATP  ATP+KLA
 7305294 Unknown KLA 1.01 1.06 1.00 1.05 .99 1.07 .99
ATP 1.00 1.05 1.06 1.03 .89 1.01 1.10
KLA/ATP 1.04 .92 1.05 1.07 1.00 1.00 1.05
Mm.26132
9
KLA  ATP  ATP+KLA
 71037402 Unknown KLA 1.53 1.44 1.59 1.66 1.72 1.88 1.09
ATP 1.08 .98 1.38 1.35 1.28 1.25 1.07
KLA/ATP 1.49 1.53 1.97 1.61 1.54 1.25 1.08
Mm.27604
2
KLA  ATP  ATP+KLA
 18702319 Unknown KLA .81 .72 .70 .70 .54 .54 .67
ATP .90 .95 1.17 1.15 1.35 1.32 1.13
KLA/ATP .70 .78 .89 .83 1.09 1.13 .97
Mm.41758
KLA  ATP  ATP+KLA
 148747503 Unknown KLA 1.68 1.98 1.80 1.70 1.53 1.43 1.42
ATP 1.05 1.08 1.12 1.06 1.09 1.51 1.15
KLA/ATP 1.74 2.06 1.81 1.45 1.47 1.42 1.55
Mm.44128
3
KLA  ATP  ATP+KLA
 149253604 Unknown KLA .66 .64 .61 .67 .60 .72 .88
ATP .71 .62 .69 .55 .46 .66 .70
KLA/ATP .58 .48 .57 .49 .50 .52 .55
Mm.45680
7
KLA  ATP  ATP+KLA
 157951728 Unknown KLA 1.00 1.02 1.05 .97 .99 .96 1.05
ATP 1.13 .98 1.00 1.06 1.02 .94 .98
KLA/ATP 1.11 .96 1.08 1.01 .99 1.01 .98
Mm.45798
3
KLA  ATP  ATP+KLA
 118131045 Unknown KLA .95 1.08 1.17 1.13 1.10 1.13 1.06
ATP 1.02 .97 1.03 1.07 1.17 1.22 1.05
KLA/ATP 1.04 1.05 1.06 1.11 1.41 1.49 1.08
Mm.46514
KLA  ATP  ATP+KLA
 114326498 Unknown KLA 1.06 .98 1.04 .98 1.00 .99 .99
ATP 1.03 .95 1.00 .93 1.00 1.00 .98
KLA/ATP 1.06 .99 .94 .95 .90 .91 1.02
Mpdz
KLA  ATP  ATP+KLA
 AK051782 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130079L03 product:multiple PDZ domain protein, full insert sequence. [AK051782] KLA .97 1.02 1.07 1.00 .99 1.05 1.07
ATP .97 1.04 1.01 1.04 1.00 1.13 1.02
KLA/ATP .99 .99 .98 1.07 1.05 1.20 1.06
Mpdz
KLA  ATP  ATP+KLA
 NM_010820 multiple PDZ domain protein (Mpdz), mRNA [NM_010820] KLA .99 .99 .98 .99 1.00 1.00 .97
ATP 1.01 1.00 1.09 .98 .99 1.03 .99
KLA/ATP .98 1.00 1.06 1.01 1.02 .96 .97
Mpp5
KLA  ATP  ATP+KLA
 BC075698 cDNA clone IMAGE:30640755, containing frame-shift errors [BC075698] KLA .93 .87 .79 .68 .81 .96 .97
ATP 1.01 1.08 .92 .93 3.29 2.21 1.39
KLA/ATP .94 .91 .76 .73 1.80 2.16 1.38
Mpp5
KLA  ATP  ATP+KLA
 NM_019579 membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) (Mpp5), mRNA [NM_019579] KLA .93 .90 .81 .78 .84 .93 .93
ATP 1.06 1.09 .97 1.09 3.90 2.42 1.49
KLA/ATP 1.04 .97 .86 .84 2.23 2.20 1.39
Mras
KLA  ATP  ATP+KLA
 NM_008624 muscle and microspikes RAS (Mras), mRNA [NM_008624] KLA .77 .76 .75 .84 .92 .87 1.35
ATP 1.02 1.00 1.11 1.14 .87 .79 .80
KLA/ATP .77 .77 .86 .78 .69 .63 .61
Myh1
KLA  ATP  ATP+KLA
 AK009974 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310058C22 product:myosin, heavy polypeptide 1, skeletal muscle, adult, full insert sequence [AK009974] KLA .98 .99 .95 1.03 .98 .98 .98
ATP .98 1.00 1.02 1.00 .99 1.01 .99
KLA/ATP .98 .95 1.05 1.06 1.01 1.00 1.06
Myh1
KLA  ATP  ATP+KLA
 NM_030679 myosin, heavy polypeptide 1, skeletal muscle, adult (Myh1), mRNA [NM_030679] KLA 1.04 .99 .98 1.04 1.04 1.00 1.05
ATP .95 1.02 1.09 1.02 .98 1.03 1.06
KLA/ATP 1.02 .98 1.05 1.01 .96 1.00 .99
Myh10
KLA  ATP  ATP+KLA
 NM_175260 myosin, heavy polypeptide 10, non-muscle (Myh10), mRNA [NM_175260] KLA 1.04 1.08 1.24 1.13 1.13 1.02 .77
ATP 1.06 1.09 1.04 1.04 .94 .84 .79
KLA/ATP 1.09 1.16 1.08 1.05 1.05 .88 .75
Myh11
KLA  ATP  ATP+KLA
 NM_013607 myosin, heavy polypeptide 11, smooth muscle (Myh11), mRNA [NM_013607] KLA 1.01 1.05 1.02 1.06 1.00 .96 1.01
ATP 1.09 .98 1.00 1.00 1.03 .97 1.13
KLA/ATP .99 1.06 1.05 1.03 .98 1.05 1.10
Myh13
KLA  ATP  ATP+KLA
 NM_001081250 myosin, heavy polypeptide 13, skeletal muscle (Myh13), mRNA [NM_001081250] KLA 1.01 1.04 1.01 .99 1.00 1.06 .97
ATP .99 1.02 1.05 1.08 .99 .98 1.01
KLA/ATP 1.01 .98 .99 1.02 1.06 1.00 1.01
Myh14
KLA  ATP  ATP+KLA
 NM_028021 myosin, heavy polypeptide 14 (Myh14), mRNA [NM_028021] KLA 1.10 1.12 1.05 1.07 1.10 1.06 1.07
ATP 1.02 1.04 1.03 1.02 1.01 1.04 1.10
KLA/ATP 1.02 1.07 1.06 1.04 1.13 1.10 1.13
Myh2
KLA  ATP  ATP+KLA
 AK036437 adult male bone cDNA, RIKEN full-length enriched library, clone:9830108D13 product:SIMILAR TO MYOSIN, HEAVY POLYPEPTIDE 2, SKELETAL MUSCLE, ADULT homolog [Mus musculus], full insert sequence. [AK036437] KLA .97 1.04 1.02 1.02 .95 1.02 .95
ATP 1.00 .98 1.05 1.00 .95 1.08 .97
KLA/ATP .95 1.00 .94 .99 .95 .98 .99
Myh2
KLA  ATP  ATP+KLA
 NM_001039545 myosin, heavy polypeptide 2, skeletal muscle, adult (Myh2), mRNA [NM_001039545] KLA .99 .98 1.03 1.02 .98 .98 1.01
ATP 1.01 .98 .98 1.01 .97 .99 .95
KLA/ATP .95 1.00 1.05 1.00 .96 .99 1.02
Myh3
KLA  ATP  ATP+KLA
 NM_001099635 myosin, heavy polypeptide 3, skeletal muscle, embryonic (Myh3), mRNA [NM_001099635] KLA 1.01 .97 .95 1.07 1.08 1.08 1.07
ATP 1.02 .97 .98 1.02 .94 .96 1.09
KLA/ATP 1.03 1.05 1.03 1.17 1.73 2.01 1.22
Myh4
KLA  ATP  ATP+KLA
 NM_010855 myosin, heavy polypeptide 4, skeletal muscle (Myh4), mRNA [NM_010855] KLA 1.06 1.00 1.00 1.02 1.06 1.06 1.01
ATP .99 1.04 1.02 .98 .96 1.02 1.06
KLA/ATP 1.01 1.00 1.00 1.04 .99 1.00 1.03
Myh6
KLA  ATP  ATP+KLA
 NM_010856 myosin, heavy polypeptide 6, cardiac muscle, alpha (Myh6), mRNA [NM_010856] KLA 1.00 1.01 1.00 .99 1.00 .98 1.02
ATP 1.00 .99 .96 .98 1.01 1.01 .98
KLA/ATP 1.03 1.04 1.01 1.01 .99 1.00 1.02
Myh7
KLA  ATP  ATP+KLA
 NM_080728 myosin, heavy polypeptide 7, cardiac muscle, beta (Myh7), mRNA [NM_080728] KLA 1.06 1.13 1.14 1.07 1.09 1.06 1.03
ATP .96 1.01 1.09 1.05 1.15 1.16 1.12
KLA/ATP 1.01 1.05 1.02 .98 1.29 1.62 1.09
Myh8
KLA  ATP  ATP+KLA
 NM_177369 myosin, heavy polypeptide 8, skeletal muscle, perinatal (Myh8), mRNA [NM_177369] KLA 1.03 .98 1.04 .99 1.02 .99 .97
ATP 1.06 1.07 .97 .99 .98 .98 1.01
KLA/ATP 1.11 1.11 1.05 1.03 .98 1.07 .95
Myh9
KLA  ATP  ATP+KLA
 NM_022410 myosin, heavy polypeptide 9, non-muscle (Myh9), transcript variant 1, mRNA [NM_022410] KLA .69 .65 .55 .57 .70 1.14 .82
ATP .91 .98 1.08 .80 .77 .99 .84
KLA/ATP .62 .66 .69 .49 .47 .54 .70
Myl2
KLA  ATP  ATP+KLA
 NM_010861 myosin, light polypeptide 2, regulatory, cardiac, slow (Myl2), mRNA [NM_010861] KLA .88 .93 .94 .95 .94 .77 .60
ATP .96 1.04 1.14 1.06 1.00 .93 .66
KLA/ATP .91 .85 1.07 1.03 .88 .79 .67
Myl7
KLA  ATP  ATP+KLA
 NM_022879 myosin, light polypeptide 7, regulatory (Myl7), mRNA [NM_022879] KLA .95 1.01 1.02 .97 1.00 1.04 1.01
ATP 1.01 1.02 .96 .98 1.00 .98 1.01
KLA/ATP .98 1.06 1.03 .97 .85 1.01 1.00
Mylc2b
KLA  ATP  ATP+KLA
 NM_023402 myosin light chain, regulatory B (Mylc2b), mRNA [NM_023402] KLA .88 .84 .82 .86 .84 1.03 1.08
ATP .97 1.02 1.12 1.24 .96 .83 1.23
KLA/ATP .84 .83 .87 .97 .86 .91 1.34
Mylc2pl
KLA  ATP  ATP+KLA
 NM_021611 myosin light chain 2, precursor lymphocyte-specific (Mylc2pl), transcript variant 1, mRNA [NM_021611] KLA .99 .97 .93 1.05 1.00 1.03 1.00
ATP .99 1.01 1.03 1.03 .98 .97 1.06
KLA/ATP .97 1.03 .93 1.01 .97 1.05 1.05
Mylpf
KLA  ATP  ATP+KLA
 NM_016754 myosin light chain, phosphorylatable, fast skeletal muscle (Mylpf), mRNA [NM_016754] KLA 1.07 1.12 1.08 1.20 1.17 1.27 1.34
ATP 1.00 .90 .98 1.08 .98 1.22 1.09
KLA/ATP 1.00 1.15 1.14 1.18 1.18 1.04 1.19
Nras
KLA  ATP  ATP+KLA
 NM_010937 neuroblastoma ras oncogene (Nras), mRNA [NM_010937] KLA 1.20 1.22 1.27 1.20 1.09 .91 .84
ATP .98 .91 .69 .61 .59 .67 .78
KLA/ATP 1.22 1.14 .97 .79 .73 .61 .72
Ocln
KLA  ATP  ATP+KLA
 NM_008756 occludin (Ocln), mRNA [NM_008756] KLA 1.02 1.04 1.03 1.03 .99 1.05 1.00
ATP 1.03 .98 1.01 1.07 1.05 1.05 1.04
KLA/ATP 1.09 1.00 1.03 1.05 1.06 1.03 1.01
Pard3
KLA  ATP  ATP+KLA
 AK076429 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832405A21 product:par-3 (partitioning defective 3) homolog (C. elegans), full insert sequence. [AK076429] KLA .96 .96 1.03 .96 1.03 .99 1.19
ATP .97 .92 1.09 .99 1.00 1.03 .94
KLA/ATP .97 1.01 .97 1.05 .98 .92 1.04
Pard3
KLA  ATP  ATP+KLA
 NM_001013580 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 2, mRNA [NM_001013580] KLA 1.02 .99 1.03 .97 1.00 .97 1.04
ATP .93 1.02 .98 .95 1.02 1.02 .98
KLA/ATP 1.04 .98 1.01 .99 .96 .91 .95
Pard3
KLA  ATP  ATP+KLA
 NM_001013581 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 1, mRNA [NM_001013581] KLA .99 1.06 1.02 1.02 1.00 .98 .95
ATP .91 1.05 1.06 .99 1.04 .89 .99
KLA/ATP .98 .97 1.09 .97 1.01 .98 1.00
Pard3
KLA  ATP  ATP+KLA
 NM_001122850 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 4, mRNA [NM_001122850] KLA 1.01 .95 1.00 1.01 1.07 .91 .99
ATP 1.00 1.01 .98 .94 1.04 .98 1.00
KLA/ATP .99 .99 1.04 1.04 1.04 1.01 1.03
Pard3
KLA  ATP  ATP+KLA
 NM_033620 par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 3, mRNA [NM_033620] KLA .92 .93 .97 .96 1.00 .99 1.02
ATP 1.08 1.03 .93 .92 .99 .97 1.00
KLA/ATP .99 1.03 1.02 1.05 .96 1.06 1.03
Pard6a
KLA  ATP  ATP+KLA
 NM_001047436 par-6 (partitioning defective 6,) homolog alpha (C. elegans) (Pard6a), transcript variant 3, mRNA [NM_001047436] KLA .85 .86 .99 1.14 1.22 1.22 1.02
ATP 1.17 1.16 1.11 1.14 .92 1.12 1.29
KLA/ATP .84 .88 1.14 1.20 1.22 1.32 1.26
Pard6b
KLA  ATP  ATP+KLA
 BC025147 par-6 (partitioning defective 6) homolog beta (C. elegans), mRNA (cDNA clone MGC:35871 IMAGE:2655658), complete cds [BC025147] KLA .97 .97 .91 .92 .92 .95 .97
ATP .97 .99 .99 .99 1.10 1.02 1.10
KLA/ATP .99 .97 .96 .95 1.10 1.11 1.13
Pard6b
KLA  ATP  ATP+KLA
 NM_021409 par-6 (partitioning defective 6) homolog beta (C. elegans) (Pard6b), mRNA [NM_021409] KLA .96 1.04 .96 1.03 .98 1.07 1.04
ATP 1.00 .92 1.02 1.01 .97 1.01 .98
KLA/ATP 1.02 .92 1.03 1.02 1.01 .97 1.01
Pard6g
KLA  ATP  ATP+KLA
 AK019835 adult male testis cDNA, RIKEN full-length enriched library, clone:4930590G08 product:unclassifiable, full insert sequence. [AK019835] KLA .95 .95 .84 .86 .78 .80 .76
ATP 1.01 .94 1.00 .88 .84 .89 .73
KLA/ATP .90 .87 .87 .81 .82 .73 .73
Pard6g
KLA  ATP  ATP+KLA
 NM_053117 par-6 partitioning defective 6 homolog gamma (C. elegans) (Pard6g), mRNA [NM_053117] KLA .92 .83 .73 .69 .56 .68 .57
ATP .98 .89 .92 .83 .69 .80 .56
KLA/ATP .86 .81 .72 .73 .66 .70 .53
Ppp2ca
KLA  ATP  ATP+KLA
 NM_019411 protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform (Ppp2ca), mRNA [NM_019411] KLA 1.17 1.13 1.18 1.20 1.54 1.45 1.34
ATP 1.09 1.20 1.07 1.33 1.56 2.04 1.43
KLA/ATP 1.14 1.17 1.15 1.49 1.59 2.37 2.02
Ppp2cb
KLA  ATP  ATP+KLA
 NM_017374 protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform (Ppp2cb), mRNA [NM_017374] KLA 1.32 1.33 1.37 1.24 1.27 1.09 1.18
ATP .94 .93 .82 .91 1.22 2.01 1.08
KLA/ATP 1.24 1.14 .80 .97 1.13 1.54 1.18
Ppp2r1a
KLA  ATP  ATP+KLA
 NM_016891 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform (Ppp2r1a), mRNA [NM_016891] KLA 1.44 1.39 1.47 1.37 1.69 1.33 1.16
ATP 1.18 1.55 .85 1.67 1.38 .99 1.24
KLA/ATP 1.66 1.98 .97 2.33 1.41 1.65 1.38
Ppp2r1b
KLA  ATP  ATP+KLA
 NM_001034085 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform (Ppp2r1b), transcript variant 1, mRNA [NM_001034085] KLA 1.26 1.17 1.14 1.13 1.12 1.11 .99
ATP .90 .90 .96 .98 1.59 1.71 1.16
KLA/ATP 1.23 1.16 .99 1.00 1.54 1.34 1.24
Ppp2r1b
KLA  ATP  ATP+KLA
 NM_028614 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform (Ppp2r1b), transcript variant 2, mRNA [NM_028614] KLA 2.38 2.38 2.53 1.80 1.52 .95 1.16
ATP 1.17 1.29 1.04 1.09 1.16 1.19 1.00
KLA/ATP 2.59 2.78 1.82 2.31 1.34 1.03 .75
Ppp2r2a
KLA  ATP  ATP+KLA
 NM_028032 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform (Ppp2r2a), mRNA [NM_028032] KLA 2.18 2.42 2.58 2.17 2.08 1.83 1.57
ATP 1.06 1.12 .90 1.28 1.76 1.70 1.39
KLA/ATP 2.55 2.38 1.62 2.68 2.25 2.55 1.86
Ppp2r2b
KLA  ATP  ATP+KLA
 AK086561 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930037C08 product:unclassifiable, full insert sequence [AK086561] KLA .94 1.02 1.07 1.02 1.02 .97 .98
ATP 1.01 1.04 1.01 .99 .97 .95 1.00
KLA/ATP 1.04 1.06 1.01 .96 1.02 .90 .93
Ppp2r2b
KLA  ATP  ATP+KLA
 NM_028392 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform (Ppp2r2b), transcript variant 2, mRNA [NM_028392] KLA 1.01 1.02 .96 1.00 1.04 1.01 1.00
ATP 1.00 .96 1.07 .93 .95 1.01 1.03
KLA/ATP .95 1.01 1.06 1.07 .98 1.02 1.03
Ppp2r2c
KLA  ATP  ATP+KLA
 NM_172994 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform (Ppp2r2c), mRNA [NM_172994] KLA .97 .98 .96 1.02 1.02 1.06 1.01
ATP .96 1.05 1.03 .98 1.01 1.04 1.06
KLA/ATP .98 .98 1.00 .96 1.00 .86 1.10
Ppp2r2d
KLA  ATP  ATP+KLA
 NM_026391 protein phosphatase 2, regulatory subunit B, delta isoform (Ppp2r2d), mRNA [NM_026391] KLA 1.07 1.03 1.14 1.18 1.16 1.27 1.13
ATP .96 .93 .95 .76 1.34 2.21 1.22
KLA/ATP 1.01 1.01 1.01 .87 1.91 2.19 2.18
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prkcd
KLA  ATP  ATP+KLA
 NM_011103 protein kinase C, delta (Prkcd), mRNA [NM_011103] KLA 1.72 1.84 1.90 1.68 2.01 1.61 1.64
ATP 1.00 1.03 .68 .81 1.38 1.26 .98
KLA/ATP 1.77 1.79 1.16 1.19 1.33 1.25 1.56
Prkce
KLA  ATP  ATP+KLA
 AK017901 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830406C15 product:unclassifiable, full insert sequence. [AK017901] KLA 1.63 1.44 1.95 2.09 1.96 1.34 1.56
ATP .99 .83 .85 .78 .85 2.44 1.47
KLA/ATP 1.36 1.45 1.44 1.23 1.30 2.39 2.29
Prkce
KLA  ATP  ATP+KLA
 AK042994 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730046G04 product:protein kinase C, epsilon, full insert sequence. [AK042994] KLA 1.01 1.07 1.03 1.03 1.04 1.00 1.06
ATP .99 1.09 1.08 1.05 1.02 1.06 1.07
KLA/ATP 1.00 .90 1.06 1.14 1.10 1.08 1.09
Prkch
KLA  ATP  ATP+KLA
 NM_008856 protein kinase C, eta (Prkch), mRNA [NM_008856] KLA .17 .14 .13 .19 .37 .78 .87
ATP 1.01 1.09 1.00 1.02 .46 .29 .78
KLA/ATP .16 .14 .15 .19 .20 .26 .87
Prkci
KLA  ATP  ATP+KLA
 NM_008857 protein kinase C, iota (Prkci), mRNA [NM_008857] KLA .92 .84 .75 .59 .50 .66 .90
ATP 1.06 1.20 1.15 1.10 1.14 1.04 1.00
KLA/ATP .83 .92 .75 .78 .99 1.06 .80
Prkcq
KLA  ATP  ATP+KLA
 AK085546 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630039J01 product:protein kinase C, theta, full insert sequence [AK085546] KLA .98 .99 1.01 1.00 .95 .98 .97
ATP 1.06 .98 1.02 1.00 .99 .99 1.04
KLA/ATP .91 1.01 .84 1.02 1.03 1.00 1.03
Prkcq
KLA  ATP  ATP+KLA
 NM_008859 protein kinase C, theta (Prkcq), mRNA [NM_008859] KLA 1.04 1.07 1.00 1.06 1.02 .91 .87
ATP 1.06 .97 .97 .99 .94 1.00 .89
KLA/ATP 1.09 1.00 1.15 1.14 .98 1.07 .96
Prkcz
KLA  ATP  ATP+KLA
 NM_008860 protein kinase C, zeta (Prkcz), transcript variant 1, mRNA [NM_008860] KLA .92 .90 1.00 .99 1.07 1.05 1.12
ATP 1.01 .95 .94 .93 1.04 1.04 .95
KLA/ATP .95 .94 .95 .94 .99 1.02 .98
Pten
KLA  ATP  ATP+KLA
 NM_008960 phosphatase and tensin homolog (Pten), mRNA [NM_008960] KLA .79 .73 .61 .59 .56 .70 1.00
ATP 1.04 1.11 1.07 1.12 1.03 1.38 .83
KLA/ATP .75 .69 .60 .74 .93 1.09 1.24
Rab13
KLA  ATP  ATP+KLA
 AK083292 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730019P10 product:unclassifiable, full insert sequence. [AK083292] KLA 1.00 .99 .99 .95 .96 .97 .98
ATP 1.00 1.06 .95 .96 1.18 1.15 .97
KLA/ATP 1.04 1.03 1.03 1.00 1.41 1.56 1.00
Rab13
KLA  ATP  ATP+KLA
 NM_026677 RAB13, member RAS oncogene family (Rab13), mRNA [NM_026677] KLA 1.10 1.09 1.19 1.26 1.20 1.22 1.18
ATP 1.04 1.12 1.03 1.24 1.12 .81 1.14
KLA/ATP 1.14 1.30 1.29 1.42 1.25 1.04 1.40
Rab3b
KLA  ATP  ATP+KLA
 NM_023537 RAB3B, member RAS oncogene family (Rab3b), mRNA [NM_023537] KLA 1.00 .98 .99 .99 .98 .97 .93
ATP 1.01 .98 1.03 1.02 .97 .98 .96
KLA/ATP .99 .96 1.00 1.03 .99 1.02 1.05
Rhoa
KLA  ATP  ATP+KLA
 NM_016802 ras homolog gene family, member A (Rhoa), mRNA [NM_016802] KLA .93 1.00 1.07 .97 1.08 1.06 1.02
ATP .93 .88 .49 .61 .63 .78 1.05
KLA/ATP .94 .92 .59 .63 .61 .78 1.12
Rras
KLA  ATP  ATP+KLA
 NM_009101 Harvey rat sarcoma oncogene, subgroup R (Rras), mRNA [NM_009101] KLA .89 .89 .99 .98 1.25 1.48 1.81
ATP 1.14 1.17 1.01 1.61 1.37 1.33 1.40
KLA/ATP 1.09 1.05 1.01 1.34 1.24 1.10 1.27
Rras2
KLA  ATP  ATP+KLA
 NM_025846 related RAS viral (r-ras) oncogene homolog 2 (Rras2), mRNA [NM_025846] KLA 7.72 7.35 7.03 5.47 3.21 1.03 .65
ATP .92 .86 .99 .95 1.86 2.13 .72
KLA/ATP 6.51 6.50 5.94 4.45 3.05 1.72 .75
Spnb2
KLA  ATP  ATP+KLA
 NM_009260 spectrin beta 2 (Spnb2), transcript variant 2, mRNA [NM_009260] KLA 1.29 1.20 1.33 1.18 1.06 .98 .94
ATP 1.08 1.09 1.19 .78 .78 .93 1.02
KLA/ATP 1.36 1.29 1.78 .97 1.02 1.00 1.05
Spnb2
KLA  ATP  ATP+KLA
 NM_175836 spectrin beta 2 (Spnb2), transcript variant 1, mRNA [NM_175836] KLA 1.15 1.10 1.31 1.24 1.11 .89 .80
ATP 1.01 1.01 1.08 .86 .71 .54 .68
KLA/ATP 1.13 1.21 1.40 1.04 .87 .82 .92
Src
KLA  ATP  ATP+KLA
 NM_009271 Rous sarcoma oncogene (Src), transcript variant 1, mRNA [NM_009271] KLA 6.99 7.23 7.54 5.99 5.34 3.39 3.00
ATP 1.02 1.06 1.06 2.08 4.41 5.03 3.97
KLA/ATP 7.44 7.51 5.48 6.24 4.86 5.86 7.90
Tjap1
KLA  ATP  ATP+KLA
 NM_028751 tight junction associated protein 1 (Tjap1), mRNA [NM_028751] KLA 1.19 1.13 1.14 1.10 1.25 1.21 1.16
ATP 1.03 1.05 .99 1.07 1.35 1.38 1.08
KLA/ATP 1.21 1.19 .95 1.03 1.24 1.44 1.61
Tjp1
KLA  ATP  ATP+KLA
 NM_009386 tight junction protein 1 (Tjp1), mRNA [NM_009386] KLA 1.00 1.03 1.07 1.00 1.03 1.03 1.09
ATP 1.01 .98 1.06 1.00 1.00 1.05 1.04
KLA/ATP .99 1.04 1.06 1.08 1.10 1.21 1.11
Tjp2
KLA  ATP  ATP+KLA
 NM_011597 tight junction protein 2 (Tjp2), mRNA [NM_011597] KLA .94 .89 .74 .67 .59 .59 .72
ATP 1.03 1.12 1.08 1.31 1.14 1.22 1.28
KLA/ATP .97 .97 .82 .84 .70 .71 1.10
Tjp3
KLA  ATP  ATP+KLA
 NM_013769 tight junction protein 3 (Tjp3), mRNA [NM_013769] KLA .54 .55 .59 .71 .71 .70 .72
ATP 1.04 1.12 1.04 1.10 .64 .51 .75
KLA/ATP .60 .62 .63 .65 .58 .56 .60
Vapa
KLA  ATP  ATP+KLA
 NM_013933 vesicle-associated membrane protein, associated protein A (Vapa), mRNA [NM_013933] KLA 1.02 1.03 1.17 1.26 1.46 1.42 1.34
ATP 1.03 1.09 1.17 1.27 1.84 2.74 1.36
KLA/ATP 1.04 1.04 1.06 1.34 1.69 2.15 1.50
Yes1
KLA  ATP  ATP+KLA
 NM_009535 Yamaguchi sarcoma viral (v-yes) oncogene homolog 1 (Yes1), mRNA [NM_009535] KLA .99 1.14 .97 .99 .99 1.02 1.05
ATP 1.07 .98 1.00 1.09 .98 .99 1.00
KLA/ATP 1.04 1.04 .89 1.01 1.04 1.02 1.07